0001562180-22-000232.txt : 20220105
0001562180-22-000232.hdr.sgml : 20220105
20220105160651
ACCESSION NUMBER: 0001562180-22-000232
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20220105
DATE AS OF CHANGE: 20220105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CRANDELL KEITH
CENTRAL INDEX KEY: 0001219039
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38319
FILM NUMBER: 22511164
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quanterix Corp
CENTRAL INDEX KEY: 0001503274
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 208957988
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 MIDDLESEX TURNPIKE
CITY: BILLERICA
STATE: MA
ZIP: 01821
BUSINESS PHONE: 617-301-9400
MAIL ADDRESS:
STREET 1: 900 MIDDLESEX TURNPIKE
CITY: BILLERICA
STATE: MA
ZIP: 01821
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-01-03
false
0001503274
Quanterix Corp
QTRX
0001219039
CRANDELL KEITH
8755 WEST HIGGINS ROAD, SUITE 1025
CHICAGO
IL
60631
true
false
true
false
Common Stock
2021-11-16
4
J
false
189311.00
0.00
D
177247.00
I
See footnote
Common Stock
2021-11-16
4
J
false
120689.00
0.00
D
113003.00
I
See Footnote
Common Stock
2021-11-16
4
J
false
9952.00
0.00
A
105964.00
D
Common Stock
2021-11-18
4
J
false
177247.00
0.00
D
0.00
I
See footnote
Common Stock
2021-11-18
4
J
false
113003.00
0.00
D
0.00
I
See Footnote
Common Stock
2021-11-18
4
J
false
9318.00
0.00
A
115282.00
D
Common Stock
2022-01-03
4
A
false
2668.00
0.00
A
117950.00
D
Common Stock
2022-01-03
4
A
false
307.00
42.41
A
118257.00
D
Stock Option (Right to Buy)
42.41
2022-01-03
4
A
false
4002.00
0.00
A
2022-12-31
2032-01-03
Common Stock
4002.00
4002.00
D
Distribution of Common Stock held by a limited partnership to its partners for no consideration.
These shares are directly held by ARCH Venture Fund VI, L.P. ("ARCH VI"). ARCH Venture Partners VI, L.P. ("GPLP"), the sole general partner of ARCH VI, may be deemed to beneficially own the shares held by ARCH VI. ARCH Venture Partners VI, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person is a managing director of the GPLLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH VI. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any.
These shares are directly held by ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"). ARCH Venture Partners VIII, LLC ("ARCH VIII LLC") the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person is a managing director of the ARCH VIII LLC and shares voting and investment control with respect to these shares. The Reporting Person may be deemed to beneficially own the shares held by ARCH Overage. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein, if any.
Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.
Represents restricted stock units that vest as to 100% of the shares on December 31, 2022 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.
Includes 2,668 restricted stock units.
Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2021.
Closing price of the Company's common stock on the Nasdaq Global Market on January 3, 2021.
Represents non-qualified stock option to purchase 4,002 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy.
/s/ Brian Keane, as Attorney-in-Fact for Keith L. Crandell
2022-01-05